Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 1961-1972

  Rajendran, Ramkumar ^a   Garva, Richa ^a   Ashour, Hassan ^a   Leung, Travis ^a   Stratford, Ian ^a   Krstic Demonacos, Marija ^a   Demonacos, Constantinos ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acetylation; Cancer; Glycolysis; Hypoxia inducible factor; Metabolism; Oxidative phosphorylation; P300 CBP associated factor; P53

Indexed keywords

ACYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; HYPOXIA INDUCIBLE FACTOR 1; LACTIC ACID; PROTEIN P53; TRANSCRIPTION FACTOR;

ACETYLATION; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CELL CYCLE ARREST; CELL ENERGY; CELL FUNCTION; CELL METABOLISM; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENERGY YIELD; ENZYME ACTIVITY; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HYPOXIA; NEOPLASM; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ACETYLATION; BINDING SITES; CARRIER PROTEINS; CELL HYPOXIA; CELL LINE, TUMOR; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENES, P53; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTIC ACID; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIAL PROTEINS; NEOPLASMS; OXIDATIVE STRESS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS;

EID: 84876526130     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1907     Document Type: Article

References (33)

1. Fantin VR, St-Pierre J and Leder P: Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434, 2006. (Pubitemid 43832190)
2. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH and Thompson CB: Growth factors can infuence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 21: 5899-5912, 2001. (Pubitemid 32737807)
3. Olovnikov IA, Kravchenko JE and Chumakov PM: Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense. Semin Cancer Biol 19: 32-41, 2009.
4. Sonveaux P, Végran F, Schroeder T, et al: Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118: 3930-3942, 2008.
5. Kroemer G and Pouyssegur J: Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482, 2008. (Pubitemid 351766797)
6. Papandreou I, Cairns RA, Fontana L, Lim AL and Denko NC: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197, 2006.
7. Semenza G: HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39: 231-234, 2007. (Pubitemid 47619375)
8. Tennant DA, Duran RV, Boulahbel H and Gottlieb E: Metabolic transformation in cancer. Carcinogenesis 30: 1269-1280, 2009.
9. Vousden KH and Ryan KM: p53 and metabolism. Nat Rev Cancer 9: 691-700, 2009.
10. Shen L, Sun X, Fu Z, Yang G, Li J and Yao L: The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy. Clin Cancer Res 18: 1561-1567, 2012.
11. Matoba S, Kang J-G, Patino WD, et al: p53 regulates mitochon-drial respiration. Science 312: 1650-1653, 2006.
12. Bensaad K, Cheung EC and Vousden KH: Modulation of intra-cellular ROS levels by TIGAR controls autophagy. EMBO J 28: 3015-3026, 2009.
13. Stiburek L and Zeman J: Assembly factors and ATP-dependent proteases in cytochrome c oxidase biogenesis. Biochim Biophys Acta 1797: 1149-1158, 2010.
14. Jaksch M, Ogilvie I, Yao J, et al: Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase defciency. Hum Mol Genet 9: 795-801, 2000. (Pubitemid 30162764)
15. Li H and Jogl G: Structural and biochemical studies of TIGAR (Tp53-induced glycolysis and apoptosis regulator). J Biol Chem 284: 1748-1754, 2009.
16. Bensaad K, Tsuruta A, Selak MA, et al: TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120, 2006. (Pubitemid 44040989)
17. Xenaki G, Ontikatze T, Rajendran R, et al: PCAF is an HIF-1[alpha] co-factor that regulates p53 transcriptional activity in hypoxia. Oncogene 27: 5785-5796, 2008.
18. Lim J-H, Lee Y-M, Chun Y-S, Chen J, Kim J-E and Park J-W: Sirtuin 1 modulates cellular responses to hypoxia by deacety-lating hypoxia-inducible factor 1α. Mol Cell 38: 864-878, 2010.
19. Fulco M, Schiltz RL, Iezzi S, et al: Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12: 51-62, 2003. (Pubitemid 36945036)
20. Motta MC, Divecha N, Lemieux M, et al: Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563, 2004. (Pubitemid 38264432)
21. Haigis MC and Sinclair DA: Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5: 253-295, 2010.
22. Sohda M, Ishikawa H, Masuda N, et al: Pretreatment evaluation of combined HIF-1α, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 110: 838-844, 2004. (Pubitemid 38758509)
23. Fritz V and Fajas L: Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 29: 4369-4377, 2010.
24. Soutoglou E, Katrakili N and Talianidis I: Acetylation regulates transcription factor activity at multiple levels. Mol Cell 5: 745-751, 2000.
25. Demonacos C, Krstic-Demonacos M and La Thangue NB: A TPR motif co-factor contributes to p300 activity in the p53 response. Mol Cell 8: 71-84, 2001. (Pubitemid 32772906)
26. Wallace DC: Bioenergetics, the origins of complexity, and the ascent of man. Proc Natl Acad Sci USA 107: 8947-8953, 2010.
27. Bensaad K and Vousden KH: p53: new roles in metabolism. Trends Cell Biol 17: 286-291, 2007. (Pubitemid 46829848)
28. Zhou S, Kachhap S and Singh KK: Mitochondrial impairment in p53-defcient human cancer cells. Mutagenesis 18: 287-292, 2003. (Pubitemid 36592423)
29. Schwartzenberg-Bar-Yoseph F, Armoni M and Karnieli E: The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 64: 2627-2633, 2004. (Pubitemid 38523921)
30. Formenti F, Constantin-Teodosiu D, Emmanuel Y, et al: Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci USA 107: 12722-12727, 2010.
31. Yalcin A, Telang S, Clem B and Chesney J: Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2, 6-bisphos-phatases in cancer. Exp Mol Pathol 86: 174-179, 2009.
32. Chesney J: 6-phosphofructo-2-kinase/fructose-2, 6-bisphospha-tase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care 9: 535-539, 2006. (Pubitemid 44258026)
33. Seyfried T and Shelton L: Cancer as a metabolic disease. Nutr Metab 7: 7, 2010.